Home » Newsletters » BioWorld Science

BioWorld Science

June 22, 2020

View Archived Issues

New renal imaging agent for the measurement of glomerular filtration rate

Selective inhibition of GSK-3alpha ameliorates the phenotype of a mouse model of fragile X syndrome

Heat Biologics initiates phase I study of PTX-35

Topline data from PRISM3 study of CP-101 for prevention of recurrent C. difficile Infection

Preclinical data presented for IDG-16177

GEMIN5 mutations linked to developmental delay, motor dysfunction and cerebellar atrophy

Serum EMC10 is tied to atherosclerosis and coronary artery disease

Tarapeutics Science patents PI3Kdelta inhibitors

Sinovent divulges Ret inhibitors

Shanghai Ennova Biopharmaceutical presents TRK inhibitors

Age and sex differences influence macrophage response

Boehringer Ingelheim Pharma describes new VNN1 inhibitors

New AR and/or GR antagonists presented by Nuvation Bio

Lasting clinical benefit seen with axi-cel CAR T-cell therapy in indolent non-Hodgkin's lymphoma

Multiracial study gives new diabetes insights

Newly identified cone-rod synaptic disorder phenotype associated with RIMS2 gene variants

Phase I trial evaluates autologous GD2 CAR T cells for DIPG and DMG

Variants in GINS3 gene result in Meier-Gorlin syndrome

Calico opens enrollment in phase I trial of ABBV-CLS-579 for locally advanced or metastatic tumors

Beneficial activity seen with ladarixin in phase II study in new-onset type 1 diabetes

Ridgeback begins phase II studies of EIDD-2801 for COVID-19

FSD reports topline data from first-in-human study of ultramicronized palmitoylethanolamide

FDA approves Gimoti for acute and recurrent diabetic gastroparesis

FDA issues new complete response letter for Contepo for cUTI

Favipiravir approved in India for mild to moderate COVID-19

New phase I trial evaluates UCD19 CAR T cells for relapsed/refractory B-cell NHL

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026